Atlas Trials

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

Clinical trial NCT07445048 · RECRUITING

Trial details

NCT number
NCT07445048
Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Head & Neck Squamous Cell CarcinomaHead & Neck CancerPostoperative Adjuvant Treatment
Start date
2026-03-04
Primary completion
2028-03-05
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.